Terbutaline Interactions

May enhance the neuromuscular blocking action of succinylcholine.

Source: NLP:succinylcholine chloride

Sympathomimetic that may reduce glucose-lowering effect of glimepiride, leading to worsening glycemic control.

Source: NLP:glimepiride

May reduce glucose-lowering effect of glipizide, leading to worsening glycemic control; monitor closely.

Source: NLP:glipizide

Sympathomimetic agent that may decrease the blood glucose lowering effect. Dose adjustment and increased glucose monitoring required.

Source: NLP:insulin aspart

May decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Source: NLP:insulin aspart-szjj

Sympathomimetic agent that may decrease blood glucose lowering effect. Dosage increases and increased glucose monitoring may be required.

Source: NLP:insulin degludec

May decrease blood glucose lowering effect of insulin glargine; dosage increases and increased glucose monitoring may be required.

Source: NLP:insulin glargine

Sympathomimetic agent may decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.

Source: NLP:insulin glulisine

Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and glucose monitoring may be required.

Source: NLP:insulin human

Sympathomimetic agent that may decrease blood glucose lowering effect; dose adjustment and increased glucose monitoring required.

Source: NLP:insulin lispro

Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.

Source: NLP:insulin lispro-aabc

Beta-agonist; may require increased dosages when used concomitantly with sotalol.

Source: NLP:sotalol hydrochloride